Clinical Epidemiology of Chronic Liver Diseases (eBook)

Robert Wong is a graduate of the University of California San Francisco School of Medicine. He completed his internship and residency in internal medicine at California Pacific Medical Center. Following residency, he completed his gastroenterology and hepatology fellowship at Stanford University Hospitals and Clinics during which time he also completed his Masters in Clinical Epidemiology. After completing fellowship, he joined the gastroenterology faculty at Alameda Health System - Highland Hospital, where he also holds an appointment as Assistant Clinical Professor of Medicine at University of California San Francisco School of Medicine. His clinical interests include viral hepatitis and chronic liver diseases. His research interests include clinical epidemiology and outcomes research with a focus on chronic liver diseases and gastrointestinal malignancies.Dr Gish has made key contributions to hepatitis research and treatment; he was a major early contributor to the decipherment of methods for the detection of hepatitis B and C virus and characterizing its epidemiology and clinical presentation in humans. He was involved in studies that led to the genotypic classification strategies and methods now in use worldwide. As of Sept 26th, Dr Gish has joined, part-time, Dr Richard Manch in Phoenix Arizona at St Joseph’s Hospital and Medical Center to help start a liver transplant program at that facility and to help expand their Liver Disease Center to enhance research and education. In April 2014, Dr Gish joined Stanford to assist with the liver program development as a Professor Consultant.

Introduction – Robert Wong, Alameda Health System and Robert Gish, Stanford University Principles of Clinical Epidemiology – Jerry Gardner, Science for Organizations Understanding Study Design for Clinical Epidemiology Studies – Irene Yen, University of California, San Francisco Understanding the Interpretation of Disease Incidence and Prevalence  – Sarah Larney, National Drug and Alcohol Research Center, Australia Understanding Survival Analyses – Jerry Gardner, Science for Organizations Epidemiology of Liver Disease – Worldwide Perspective – Nimzing Ladep, Imperial College London and Mamun Al-Mahtab, Bangabandhu Sheikh Mujib Medical University Epidemiology of Liver Disease in the U.S. – Michael Volk,  Loma Linda Alcoholic Liver Disease – Ashwani Singal, University of Alabama Hepatitis B Virus – The Asian Perspective – Man-Fung Yuen, University of Hong Kong Hepatitis B Virus – The African Perspective – Ramou Njie, MRC Unit Gambia  Hepatitis B Virus – Western Perspective – Robert Wong, Alameda Health System and Robert Gish, Stanford University Hepatitis D Virus – Mario Rizzetto, University of Torino, Molinette Hospital Hepatitis C Virus – Joseph Lim, Yale University and Imam Waked, National Liver Institute Egypt Hepatitis A  and Hepatitis E Virus - Mohammad Sultan Khuroo, Kashmir, India and Elisabetta Franco, Rome, Italy Nonalcoholic Fatty Liver Disease – Edward Holt, California Pacific Medical Center Hepatocellular Carcinoma – Hashem El-Serag, Baylor Medical Center, Houston Autoimmune Liver Diseases and Cholestatic Liver Diseases – Michael Manns, Hannover Medical School, Germany Genetic and Inherited Liver Diseases - Kris Kowdley, University of Washington Cryptogenic Liver Diseases and other – Peter Bypass, University of Aberdeen Summary – Robert Wong, Alameda Health System and Robert Gish, Stanford University